209256-62-2 Usage
Uses
Used in Pharmaceutical Industry:
3,4-Dihydro-2H-1,5-benzodioxepine-6-carbaldehyde is used as a key intermediate in the synthesis of various pharmaceutical compounds for its reactivity and functional properties. It contributes to the development of new drugs with potential therapeutic benefits.
Used in Agrochemical Industry:
In the agrochemical sector, 3,4-Dihydro-2H-1,5-benzodioxepine-6-carbaldehyde serves as a building block for the creation of novel agrochemicals, such as pesticides and herbicides. Its unique structure and reactivity allow for the design of effective and targeted agrochemicals to improve crop protection and yield.
Used in Materials Science:
3,4-Dihydro-2H-1,5-benzodioxepine-6-carbaldehyde is utilized in materials science for the development of advanced materials with specific properties. Its functional groups and reactivity enable the creation of new polymers, composites, or other materials with applications in various industries, such as electronics, automotive, or aerospace.
Check Digit Verification of cas no
The CAS Registry Mumber 209256-62-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,0,9,2,5 and 6 respectively; the second part has 2 digits, 6 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 209256-62:
(8*2)+(7*0)+(6*9)+(5*2)+(4*5)+(3*6)+(2*6)+(1*2)=132
132 % 10 = 2
So 209256-62-2 is a valid CAS Registry Number.
InChI:InChI=1/C10H10O3/c11-7-8-3-1-4-9-10(8)13-6-2-5-12-9/h1,3-4,7H,2,5-6H2
209256-62-2Relevant articles and documents
Imidazo ring PAR4 antagonist and medical applications thereof
-
Paragraph 0290-0293, (2020/01/12)
The invention relates to an imidazo ring compound represented by formula (I) or formula (II), or a pharmaceutically acceptable salt or ester or solvate thereof. The compound disclosed by the inventioncan be used for preparing medicines for preventing or treating thromboembolic diseases.
Novel use of amine compounds
-
, (2018/06/28)
The invention provides a preparation method and novel use of amine compounds. Specifically, the invention provides compounds shown in the formula A or their optical isomers, racemes, solvates or pharmaceutically acceptable salts and a medical use thereof. The above compounds can be used for preparation of a pharmaceutical composition or a preparation. The pharmaceutical composition or preparationis used for (a) inhibiting a transient receptor potential channel protein TRPA1 and (b) treating diseases associated with the transient receptor potential channel protein, wherein each group is defined in the specification.
BENZODIOXOLE, BENZOFURAN, DIHYDROBENZOFURAN, AND BENZODIOXANE MELATONERGIC AGENTS
-
Page/Page column 21, (2010/02/09)
Novel derivatives of benzodioxa alkylene ethers are provided which are useful as melatonergic agents.